Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States.
Center for Healthy Aging, The Pennsylvania State University, University Park, Pennsylvania, United States.
Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H364-H369. doi: 10.1152/ajpheart.00204.2024. Epub 2024 Jun 7.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 to 10 M, 33°C) alone and in combination with 15 mM -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both < 0.0001), whereas the l-NAME-sensitive component was not different ( = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
转录调节因子核因子-κB(NF-κB)是内皮功能障碍的介导者。使用柳氮磺胺吡啶抑制 NF-κB 被用于研究导致加速心血管疾病风险的炎症机制。然而,在没有疾病的情况下,NF-κB 的抑制会影响氧化还原机制,导致内皮功能异常下降。本研究旨在测量生殖期健康女性中转录调节因子 NF-κB 抑制期间的微血管内皮功能。采用随机、单盲、交叉、安慰剂对照设计,将 9 名健康女性随机分配接受口服柳氮磺胺吡啶(1500mg,每日 2 次)或安慰剂治疗 5 天。受试者通过皮内微透析单独接受内皮依赖性激动剂乙酰胆碱(ACh,10 至 10 M,33°C)和与 15mM -硝基-l-精氨酸甲酯 [l-NAME;非选择性一氧化氮(NO)合酶抑制剂] 的组合进行分级灌注。在每个微透析部位测量激光多普勒通量,并计算血流介导的血管舒张(CVC)作为通量除以平均动脉压并归一化为特定部位的最大值(CVC;28mM 硝普钠+43°C)。通过 l-NAME 敏感成分计算出剂量反应曲线下的差异。在安慰剂和柳氮磺胺吡啶治疗期间,与对照部位相比,l-NAME 部位减少(均 <0.0001)。在整个治疗过程中,对照部位和 l-NAME 部位之间存在显著差异,在柳氮磺胺吡啶治疗后,两个部位均向上移动(均 <0.0001),而 l-NAME 敏感成分没有差异(=0.94)。这些数据表明,抑制转录调节因子 NF-κB 通过非一氧化氮(NO)依赖机制改善生殖期健康女性的皮肤微血管功能。转录因子核因子-κB(NF-κB)通过编码参与炎症的基因来调节先天和适应性免疫的多个方面,并影响 NF-κB 抑制后内皮功能。我们的结果表明,生殖期健康女性中柳氮磺胺吡啶治疗后,皮肤微血管功能通过非一氧化氮(NO)依赖机制增加。